Thought of the Week: What We Give
July 17, 2025
Thought of the Week: Be Swift to Love
070902 - 560x372
Related:
Thought of the Week: Dissolving the Pain
July 9, 2025
Thought of the Week: What I Can Do
July 1, 2025
Thought of the Week – Kindness Grows Abundant
June 17, 2025
As I Grow Older
June 11, 2025
Honoring Dad on Father’s Day
June 10, 2025
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Caregiving
Effects of Lying to a Dementia Patient
ETHICS VIDEO: 3 professors at the prestigious Stanford University Center for Ethics in Society share differing thoughts on respecting the autonomy of people with dementia,
3 Comments
Diagnosis
F18 Alzheimer’s Scan Delivers Better Prescriptions & Fewer Tests
DIAGNOSIS VIDEO + ARTICLE: Today’s state-of-the-art in diagnosing Alzheimer’s is the F18 PET Scan. See how it changed one man’s life. Learn how 87% of
6 Comments
Drugs:Dementia
Razadyne For Alzheimer’s: Improves Thinking, Lifespan
MEDICATION: Razadyne (generic galantamine) is an FDA-Approved daffodil extract for Alzheimer’s. Learn how it significantly lowered mortality & eased cognitive decline.
9 Comments
Clinical Trials
Gantenerumab Cut Alzheimer’s Risk by 50% in New Study
Participants in a new study had inherited genetic variants that lead to early-onset Alzheimer’s. Among those who received the drug the longest – an average of eight years – the treatment lowered the risk of developing symptoms from essentially 100% to about 50%.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On
love this